Cargando…
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis
IMPORTANCE: Ketamine hydrochloride is increasingly used to treat depression and other psychiatric disorders but can induce schizophrenia-like or psychotomimetic symptoms. Despite this risk, the consistency and magnitude of symptoms induced by ketamine or what factors are associated with these sympto...
Autores principales: | Beck, Katherine, Hindley, Guy, Borgan, Faith, Ginestet, Cedric, McCutcheon, Robert, Brugger, Stefan, Driesen, Naomi, Ranganathan, Mohini, D’Souza, Deepak Cyril, Taylor, Matthew, Krystal, John H., Howes, Oliver D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243091/ https://www.ncbi.nlm.nih.gov/pubmed/32437573 http://dx.doi.org/10.1001/jamanetworkopen.2020.4693 |
Ejemplares similares
-
The effect of ketamine on psychopathology and implications for understanding schizophrenia and its therapeutic use: a meta-analysis
por: Beck, Katherine, et al.
Publicado: (2021) -
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
por: Hindley, Guy, et al.
Publicado: (2020) -
The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species
por: Borgan, Faith, et al.
Publicado: (2019) -
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019) -
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
por: Howes, O D, et al.
Publicado: (2017)